Overall, the results of our study suggest that COL4A1 overexpression in stromal cells may function as a potential regulator of the tumor-supporting TME composition associated with the poor prognosis of patients with LGG, PAAD, SKCM, and STAD. Here, COL4A1 is linked to neoplasm.